2024年美国糖尿病学会《糖尿病诊疗标准》解读——糖尿病诊断和分型  

Interpretation of 2024 American Diabetes Association's Standards of Care in Diabetes——diabetes diagnosis and classification

作　　者：李延兵[1] LI Yanbing(Department of Endocrinology,First Affiliated Hospital of Sun Yat-sen University,Guangdong Guangzhou 510080,China)

机构地区：[1]中山大学附属第一医院内分泌科,广东广州510080

出　　处：《诊断学理论与实践》2024年第5期467-473,共7页Journal of Diagnostics Concepts & Practice

摘　　要：糖尿病是一种常见的慢性疾病,在全球范围内造成了重大的卫生经济负担。糖尿病具有高度异质性,准确诊断和分型是实现糖尿病标准化精准治疗、改善患者临床结局的前提。近期,美国糖尿病协会(American Diabetes Association,ADA)发布了2024年《糖尿病诊疗标准》。糖尿病诊断和分型章节结合当前的最新进展,对非典型糖尿病的鉴别诊断、不同类型糖尿病的筛查、诊断和随访等流程均提出了推荐意见。本文对该指南这一部分内容进行了解读,以期为我国内分泌领域医务人员进行糖尿病诊断、分型和个体化诊疗实践提供参考。Diabetes is a common chronic disease,which has caused a significant health and economic burden worldwide.Diabetes is highly heterogeneous.Accurate diagnosis and classification are the premises to achieve standardized and accurate treatment of diabetes and improve the clinical outcomes of patients.Recently,the American Diabetes Association(ADA) issued the 2024 Standards of Medical Care in Diabetes.In the chapter on diabetes diagnosis and classification,the latest developments have been taken into account,with recommended approaches for the differential diagnosis of atypical diabetes,screening,diagnosis,and follow-up processes of different types of diabetes.This article interprets this section of the guidelines to provide a reference for healthcare professionals in the endocrine field in China for the accurate diagnosis,classification,and individualized treatment of diabetes.

关 键 词：糖尿病 诊断 分型 美国糖尿病学会 

分 类 号：R587.1[医药卫生—内分泌] R446[医药卫生—内科学]